1,073
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Rubus chingii Hu relieved the polycystic ovary syndrome with enhanced insulin sensitivity through inhibiting TXNIP/NLRP3 inflammasome signaling

, , , , &
Article: 2237116 | Received 14 Dec 2022, Accepted 10 Jul 2023, Published online: 25 Jul 2023

References

  • Azziz R. Polycystic ovary syndrome. Obstet Gynecol. 2018;132(2):1–8. doi: 10.1097/AOG.0000000000002698.
  • Gu Y, Zhou G, Zhou F, et al. Life modifications and PCOS: old story but new tales. Front Endocrinol (Lausanne). 2022;13:808898. doi: 10.3389/fendo.2022.808898.
  • Jin P, Xie Y. Treatment strategies for women with polycystic ovary syndrome. Gynecol Endocrinol. 2018;34(4):272–277. doi: 10.1080/09513590.2017.1395841.
  • Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018;14(5):270–284. doi: 10.1038/nrendo.2018.24.
  • Patel S. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. J Steroid Biochem Mol Biol. 2018;182:27–36. doi: 10.1016/j.jsbmb.2018.04.008.
  • Shang Y, Zhou H, Hu M, et al. Effect of diet on insulin resistance in polycystic ovary syndrome. J Clin Endocrinol Metab. 2020;105(10):dgaa425. doi: 10.1210/clinem/dgaa425.
  • Zhao H, Xing C, Zhang J, et al. Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: a network meta-analysis. Reprod Health. 2021;18(1):171. doi: 10.1186/s12978-021-01207-7.
  • Morgante G, Massaro MG, Di Sabatino A, et al. Therapeutic approach for metabolic disorders and infertility in women with PCOS. Gynecol Endocrinol. 2018;34(1):4–9. doi: 10.1080/09513590.2017.1370644.
  • Moini Jazani A, Nasimi Doost Azgomi H, Nasimi Doost Azgomi A, et al. A comprehensive review of clinical studies with herbal medicine on polycystic ovary syndrome (PCOS). Daru. 2019;27(2):863–877. doi: 10.1007/s40199-019-00312-0.
  • Su XH, Duan R, Sun YY, et al. Cardiovascular effects of ethanol extract of Rubus chingii Hu (Rosaceae) in rats: an in vivo and in vitro approach. J Physiol Pharmacol. 2014;65:417–424.
  • Zeng HJ, Liu Z, Wang YP, et al. Studies on the anti-aging activity of a glycoprotein isolated from Fupenzi (Rubus chingii Hu.) and its regulation on klotho gene expression in mice kidney. Int J Biol Macromol. 2018;119:470–476. doi: 10.1016/j.ijbiomac.2018.07.157.
  • Litwiniuk A, Bik W, Kalisz M, et al. Inflammasome NLRP3 potentially links obesity-associated low-grade systemic inflammation and insulin resistance with Alzheimer’s disease. Int J Mol Sci. 2021;22(11):5603. doi: 10.3390/ijms22115603.
  • He M, Chiang HH, Luo H, et al. An acetylation switch of the NLRP3 inflammasome regulates aging-associated chronic inflammation and insulin resistance. Cell Metab. 2020;31(3):580–591.e585. doi: 10.1016/j.cmet.2020.01.009.
  • Cao J, Peng Q. NLRP3 inhibitor tranilast attenuates gestational diabetes mellitus in a genetic mouse model. Drugs R D. 2022;22(1):105–112. doi: 10.1007/s40268-022-00382-7.
  • Liu Y, Liu H, Li Z, et al. The release of peripheral immune inflammatory cytokines promote an inflammatory cascade in PCOS patients via altering the follicular microenvironment. Front Immunol. 2021;12:685724. doi: 10.3389/fimmu.2021.685724.
  • Ibrahim YF, Alorabi M, Abdelzaher WY, et al. Diacerein ameliorates letrozole-induced polycystic ovarian syndrome in rats. Biomed Pharmacother. 2022;149:112870. doi: 10.1016/j.biopha.2022.112870.
  • Zhang M, Hu G, Shao N, et al. Thioredoxin-interacting protein (TXNIP) as a target for Alzheimer’s disease: flavonoids and phenols. Inflammopharmacology. 2021;29(5):1317–1329. doi: 10.1007/s10787-021-00861-4.
  • Kim EJ, Jang M, Choi JH, et al. An improved dehydroepiandrosterone-induced rat model of polycystic ovary syndrome (PCOS): post-pubertal improve PCOS’s features. Front Endocrinol (Lausanne). 2018;9:735. doi: 10.3389/fendo.2018.00735.
  • Morsi AA, E AM, Razik HFA, et al. Histomorphological changes in a rat model of polycystic ovary syndrome and the contribution of stevia leaf extract in modulating the ovarian fibrosis, VEGF, and TGF-β immunoexpressions: comparison with metformin. Acta Histochem Cytochem. 2022;55(1):9–23. doi: 10.1267/ahc.21-00081.
  • Coniglio RI, Meroño T, Montiel H, et al. HOMA-IR and non-HDL-C as predictors of high cholesteryl ester transfer protein activity in patients at risk for type 2 diabetes. Clin Biochem. 2012;45(7-8):566–570. doi: 10.1016/j.clinbiochem.2012.02.005.
  • Abraham Gnanadass S, Divakar Prabhu Y, Valsala Gopalakrishnan A. Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update. Arch Gynecol Obstet. 2021;303(3):631–643. doi: 10.1007/s00404-020-05951-2.
  • Hernández-Jiménez JL, Barrera D, Espinoza-Simón E, et al. Polycystic ovarian syndrome: signs and feedback effects of hyperandrogenism and insulin resistance. Gynecol Endocrinol. 2022;38(1):2–9. doi: 10.1080/09513590.2021.2003326.
  • Wu LM, Wang YX, Zhan Y, et al. Dulaglutide, a long-acting GLP-1 receptor agonist, can improve hyperandrogenemia and ovarian function in DHEA-induced PCOS rats. Peptides. 2021;145:170624. doi: 10.1016/j.peptides.2021.170624.
  • Kim KE, Heo JS, Han S, et al. Blood concentrations of lipopolysaccharide-binding protein, high-sensitivity C-reactive protein, tumor necrosis factor-α, and Interleukin-6 in relation to insulin resistance in young adolescents. Clin Chim Acta. 2018;486:115–121. doi: 10.1016/j.cca.2018.07.042.
  • Rudnicka E, Suchta K, Grymowicz M, et al. Chronic low grade inflammation in pathogenesis of PCOS. Int J Mol Sci. 2021;22(7):3789. doi: 10.3390/ijms22073789.
  • Lee SH, Park SY, Choi CS. Insulin resistance: from mechanisms to therapeutic strategies. Diabetes Metab J. 2022;46(1):15–37. doi: 10.4093/dmj.2021.0280.
  • Zeng X, Xie YJ, Liu YT, et al. Polycystic ovarian syndrome: correlation between hyperandrogenism, insulin resistance and obesity. Clin Chim Acta. 2020;502:214–221. doi: 10.1016/j.cca.2019.11.003.
  • Wang J, Wu D, Guo H, et al. Hyperandrogenemia and insulin resistance: the chief culprit of polycystic ovary syndrome. Life Sci. 2019;236:116940. doi: 10.1016/j.lfs.2019.116940.
  • Ren N, Kim E, Li B, et al. Flavonoids alleviating insulin resistance through inhibition of inflammatory signaling. J Agric Food Chem. 2019;67(19):5361–5373. doi: 10.1021/acs.jafc.8b05348.
  • Xiang S, Xia MF, Song JY, et al. Effect of electro-acupuncture on expression of IRS-1/PI3K/GLUT4 pathway in ovarian granulosa cells of infertile patients with polycystic ovary syndrome-insulin resistance of phlegm-dampness syndrome. Chin J Integr Med. 2021;27(5):330–335. doi: 10.1007/s11655-020-3219-z.
  • Peng MF, Tian S, Song YG, et al. Effects of total flavonoids from Eucommia ulmoides Oliv. leaves on polycystic ovary syndrome with insulin resistance model rats induced by letrozole combined with a high-fat diet. J Ethnopharmacol. 2021;273:113947. doi: 10.1016/j.jep.2021.113947.
  • Liu S, Zhang Y, Yang F, et al. Modified Cangfu Daotan decoction ameliorates polycystic ovary syndrome with insulin resistance via NF-κB/LCN-2 signaling pathway in inflammatory microenvironment. Front Endocrinol (Lausanne). 2022;13:975724. doi: 10.3389/fendo.2022.975724.
  • Abais JM, Xia M, Li G, et al. Nod-like receptor protein 3 (NLRP3) inflammasome activation and podocyte injury via thioredoxin-interacting protein (TXNIP) during hyperhomocysteinemia. J Biol Chem. 2014;289(39):27159–27168. doi: 10.1074/jbc.M114.567537.
  • Wu J, Wu Y, Zhang X, et al. Elevated serum thioredoxin-interacting protein in women with polycystic ovary syndrome is associated with insulin resistance. Clin Endocrinol (Oxf). 2014;80(4):538–544. doi: 10.1111/cen.12192.
  • Nasoohi S, Parveen K, Ishrat T. Metabolic syndrome, brain insulin resistance, and Alzheimer’s disease: thioredoxin interacting protein (TXNIP) and inflammasome as core amplifiers. J Alzheimers Dis. 2018;66(3):857–885. doi: 10.3233/JAD-180735.
  • Masters SL, Dunne A, Subramanian SL, et al. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes. Nat Immunol. 2010;11(10):897–904. doi: 10.1038/ni.1935.
  • Li M, Zhang Y, Cao Y, et al. Icariin ameliorates palmitate-induced insulin resistance through reducing thioredoxin-interacting protein (TXNIP) and suppressing ER stress in C2C12 myotubes. Front Pharmacol. 2018;9:1180. doi: 10.3389/fphar.2018.01180.
  • Zhao W, Pu M, Shen S, et al. Geniposide improves insulin resistance through AMPK-mediated txnip protein degradation in 3T3-L1 adipocytes. Acta Biochim Biophys Sin (Shanghai). 2021;53(2):160–169. doi: 10.1093/abbs/gmaa157.
  • Wang Y, Yang J, Wang Y, et al. Upregulation of TXNIP contributes to granulosa cell dysfunction in polycystic ovary syndrome via activation of the NLRP3 inflammasome. Mol Cell Endocrinol. 2023;561:111824. doi: 10.1016/j.mce.2022.111824.
  • Hou J, Lei Z, Cui L, et al. Polystyrene microplastics lead to pyroptosis and apoptosis of ovarian granulosa cells via NLRP3/Caspase-1 signaling pathway in rats. Ecotoxicol Environ Saf. 2021;212:112012. doi: 10.1016/j.ecoenv.2021.112012.
  • Wang D, Weng Y, Zhang Y, et al. Exposure to hyperandrogen drives ovarian dysfunction and fibrosis by activating the NLRP3 inflammasome in mice. Sci Total Environ. 2020;745:141049. doi: 10.1016/j.scitotenv.2020.141049.